Atlas Trials

Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients

Clinical trial NCT01897051 · UNKNOWN

Trial details

NCT number
NCT01897051
Sponsor
Yonsei University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Liver CirrhosisPortal Hypertension
Start date
2013-07-01
Primary completion
2017-02-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.